Clinical trial

IBI3042 Study in Healthy Participants and Overweight or Obese Participants

NCT07793019

StatusRECRUITING

Study typeINTERVENTIONAL

Start date2026-09-07

PhasePHASE1

Study timeline

Study start (actual)2026-09-07Date precision: day

Registry last updated2026-09-11

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Overweightunresolved

Healthy Participantsunresolved

Obesityunresolved

Interventions

OrforglipronDRUG · verified · RxNorm: orforglipron

Matching PlaceboDRUG

IBI3042DRUG

Sponsors & collaborators

Innovent Biologics (Suzhou) Co. Ltd.lead sponsor

Mapped research locations

BeijingBeijing Municipality, China1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT07793019 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.